Enavogliflozin
Modify Date: 2024-01-03 12:02:27
Enavogliflozin structure
|
Common Name | Enavogliflozin | ||
|---|---|---|---|---|
| CAS Number | 1415472-28-4 | Molecular Weight | 446.92 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 666.1±55.0 °C at 760 mmHg | |
| Molecular Formula | C24H27ClO6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 356.7±31.5 °C | |
Use of EnavogliflozinEnavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor[1][2][3]. |
| Name | (1S)-1,5-Anhydro-1-[7-chloro-6-(4-cyclopropylbenzyl)-2,3-dihydro-1-benzofuran-4-yl]-D-glucitol |
|---|---|
| Synonym | More Synonyms |
| Description | Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
SGLT2 |
| In Vitro | Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor[1][2][3]. |
| References |
[1]. Daewoong speeds up developing antidiabetic Enavogliflozin [2]. These are the results of clinical trials of the diabetes drug Enavogliflozin and Metformin |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 666.1±55.0 °C at 760 mmHg |
| Molecular Formula | C24H27ClO6 |
| Molecular Weight | 446.92 |
| Flash Point | 356.7±31.5 °C |
| Exact Mass | 446.149628 |
| LogP | 4.90 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.666 |
| D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)- |
| (1S)-1,5-Anhydro-1-[7-chloro-6-(4-cyclopropylbenzyl)-2,3-dihydro-1-benzofuran-4-yl]-D-glucitol |